Bolivia, Plurinational State of vs Chile: Access to anti-retroviral drugs, female
Bolivia, Plurinational State of
62.0%
in 2024
Chile
63.0%
in 2024
Bolivia, Plurinational State of rank
99th
Chile rank
96th
Access to anti-retroviral drugs, female over time
- Bolivia, Plurinational State of
- Chile
How they compare
Chile currently reports 63.0% against 62.0% in Bolivia, Plurinational State of, a difference of 1.0%.
Across all 25 years both countries report, Chile has been ahead every year.
Bolivia, Plurinational State of ranks 99th and Chile ranks 96th of 141 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 29.7% | 27.6% | Chile |
| 2010s | 29.4% | 56.4% | 27.0% | Chile |
| 2020s | 57.6% | 65.6% | 8.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bolivia, Plurinational State of or Chile?
- Chile, at 63.0% against 62.0% in Bolivia, Plurinational State of as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bolivia, Plurinational State of and Chile?
- 1.0%, with Chile ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Chile?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia, Plurinational State of and Chile rank globally for access to anti-retroviral drugs, female?
- Bolivia, Plurinational State of ranks 99th and Chile ranks 96th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.